Joanne C. Brown

Leeds Institute Of Medical Research At St James's, St. James's University Hospital, Beckett Street
Leeds, ENG LS97TF, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 9 publications

A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.

A prognostic microRNA-based signature for localized clear cell renal cell carcinoma: the Bio-miR study.

Journal: British journal of cancer
Published: November 04, 2024

Long-read RNA sequencing of archival tissues reveals novel genes and transcripts associated with clear cell renal cell carcinoma recurrence and immune evasion.

Long-read RNA sequencing of archival tissues reveals novel genes and transcripts associated with clear cell renal cell carcinoma recurrence and immune evasion.

Journal: Genome research
Published: December 19, 2023

Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).

Standard Versus Modified Ipilimumab, in Combination With Nivolumab, in Advanced Renal Cell Carcinoma: A Randomized Phase II Trial (PRISM).

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: November 06, 2023

Feasibility and acceptability of continuous glucose monitoring in pregnancy for the diagnosis of gestational diabetes: A single-centre prospective mixed methods study.

Feasibility and acceptability of continuous glucose monitoring in pregnancy for the diagnosis of gestational diabetes: A single-centre prospective mixed methods study.

Journal: PloS one
Published: March 20, 2023

Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling.

Molecular profile of pure squamous cell carcinoma of the bladder identifies major roles for OSMR and YAP signalling.

Journal: The journal of pathology. Clinical research
Published: December 10, 2021

Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.

Stage-stratified molecular profiling of non-muscle-invasive bladder cancer enhances biological, clinical, and therapeutic insight.

Journal: Cell reports. Medicine
Published: February 09, 2021

An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial.

An epitope-based approach of HLA-matched platelets for transfusion: a noninferiority crossover randomized trial.

Journal: Blood
Published: May 22, 2020

Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion.

Dysregulation at multiple points of the kynurenine pathway is a ubiquitous feature of renal cancer: implications for tumour immune evasion.

Journal: British journal of cancer
Published: November 14, 2019

PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma.

PRISM protocol: a randomised phase II trial of nivolumab in combination with alternatively scheduled ipilimumab in first-line treatment of patients with advanced or metastatic renal cell carcinoma.

Journal: BMC cancer
Published: August 19, 2019
Showing 1-9 of 9

Last Updated: 09/26/2026